The Regional Oncology Liaison will be responsible for launching and growing the Oncotype DX Breast Recurrence Score Program assay in Japan, supporting treatment decision-making for early stage breast cancer patients.
Base: ¥8,600,000 - ¥12,900,000; Bonus/Equity: Eligible for bonus; Benefits: Comprehensive employee benefits and possible relocation support
Must-have
Nice-to-have
Authorization to work in Japan required